SelectQuote, Inc. (NYSE:SLQT – Get Free Report) Director Denise L. Devine purchased 4,000 shares of the business’s stock in a transaction that occurred on Friday, March 14th. The stock was bought at an average cost of $3.62 per share, for a total transaction of $14,480.00. Following the completion of the acquisition, the director now directly owns 318,583 shares in the company, valued at $1,153,270.46. The trade was a 1.27 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
SelectQuote Price Performance
Shares of NYSE:SLQT traded up $0.10 on Wednesday, hitting $3.62. The company’s stock had a trading volume of 721,219 shares, compared to its average volume of 1,273,905. The company has a market capitalization of $622.30 million, a PE ratio of -40.17 and a beta of 1.13. The company has a debt-to-equity ratio of 2.10, a current ratio of 6.36 and a quick ratio of 6.36. The company has a 50-day simple moving average of $4.40 and a 200 day simple moving average of $3.28. SelectQuote, Inc. has a 1 year low of $1.48 and a 1 year high of $6.86.
SelectQuote (NYSE:SLQT – Get Free Report) last announced its earnings results on Monday, February 10th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. Sell-side analysts forecast that SelectQuote, Inc. will post -0.07 EPS for the current fiscal year.
Hedge Funds Weigh In On SelectQuote
Analyst Upgrades and Downgrades
A number of analysts have issued reports on SLQT shares. Noble Financial raised SelectQuote to a “strong-buy” rating in a research report on Wednesday, February 12th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $4.00 target price on shares of SelectQuote in a research note on Friday, November 22nd.
Read Our Latest Report on SLQT
About SelectQuote
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Stories
- Five stocks we like better than SelectQuote
- Bank Stocks – Best Bank Stocks to Invest In
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What Are Trending Stocks? Trending Stocks Explained
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How is Compound Interest Calculated?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.